Selected research
Industry Growth & Trends
Global Ringworm Treatment Drugs Industry Growth and Trends Forecast to 2032
Market perspective
The global Ringworm Treatment Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Ringworm Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Ringworm Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Ringworm Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Ringworm Treatment Drugs include Teva Pharmaceuticals, Inc., Novartis AG, Merck & Co., In, GlaxoSmithKline Plc, Taro Ppharmaceutical Industries Ltd., Perrigo Company plc, Glenmark Pharmaceuticals Inc., Chempro Group India and Avik Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Ringworm Treatment Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Ringworm Treatment Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ringworm Treatment Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ringworm Treatment Drugs.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Ringworm Treatment Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Ringworm Treatment Drugs Market by Company
Teva Pharmaceuticals, Inc.
Novartis AG
Merck & Co., In
GlaxoSmithKline Plc
Taro Ppharmaceutical Industries Ltd.
Perrigo Company plc
Glenmark Pharmaceuticals Inc.
Chempro Group India
Avik Pharma
Actiza Pharmaceutical
Ringworm Treatment Drugs Segment by Type
Anti-infective
Antifungals
Steroids
Others
Ringworm Treatment Drugs Segment by Application
Hospital Pharmacies
Drug Stores
E-commerce
Other
Ringworm Treatment Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ringworm Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ringworm Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ringworm Treatment Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ringworm Treatment Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Ringworm Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Anti-infective
- Antifungals
- Steroids
- Others
Applications
- Hospital Pharmacies
- Drug Stores
- E-commerce
- Other
Companies covered
- Teva Pharmaceuticals, Inc.
- Novartis AG
- Merck & Co., In
- GlaxoSmithKline Plc
- Taro Ppharmaceutical Industries Ltd.
- Perrigo Company plc
- Glenmark Pharmaceuticals Inc.
- Chempro Group India
- Avik Pharma
- Actiza Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Ringworm Treatment Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Ringworm Treatment Drugs Sales Estimates and Forecasts (2021-2032)
- 1.3 Ringworm Treatment Drugs Market by Type
- 1.3.1 Anti-infective
- 1.3.2 Antifungals
- 1.3.3 Steroids
- 1.3.4 Others
- 1.4 Global Ringworm Treatment Drugs Market Size by Type
- 1.4.1 Global Ringworm Treatment Drugs Market Size Overview by Type (2021-2032)
- 1.4.2 Global Ringworm Treatment Drugs Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Ringworm Treatment Drugs Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Ringworm Treatment Drugs Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Ringworm Treatment Drugs Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Ringworm Treatment Drugs Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Ringworm Treatment Drugs Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Ringworm Treatment Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Ringworm Treatment Drugs Industry Trends
- 2.2 Ringworm Treatment Drugs Industry Drivers
- 2.3 Ringworm Treatment Drugs Industry Opportunities and Challenges
- 2.4 Ringworm Treatment Drugs Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Ringworm Treatment Drugs Revenue (2021-2026)
- 3.2 Global Top Players by Ringworm Treatment Drugs Sales (2021-2026)
- 3.3 Global Top Players by Ringworm Treatment Drugs Price (2021-2026)
- 3.4 Global Ringworm Treatment Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ringworm Treatment Drugs Major Company Production Sites & Headquarters
- 3.6 Global Ringworm Treatment Drugs Company, Product Type & Application
- 3.7 Global Ringworm Treatment Drugs Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Ringworm Treatment Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Ringworm Treatment Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Ringworm Treatment Drugs Tier 1, Tier 2, and Tier 3
4 Ringworm Treatment Drugs Regional Status and Outlook
- 4.1 Global Ringworm Treatment Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Ringworm Treatment Drugs Historic Market Size by Region
- 4.2.1 Global Ringworm Treatment Drugs Sales in Volume by Region (2021-2026)
- 4.2.2 Global Ringworm Treatment Drugs Sales in Value by Region (2021-2026)
- 4.2.3 Global Ringworm Treatment Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Ringworm Treatment Drugs Forecasted Market Size by Region
- 4.3.1 Global Ringworm Treatment Drugs Sales in Volume by Region (2027-2032)
- 4.3.2 Global Ringworm Treatment Drugs Sales in Value by Region (2027-2032)
- 4.3.3 Global Ringworm Treatment Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ringworm Treatment Drugs by Application
- 5.1 Ringworm Treatment Drugs Market by Application
- 5.1.1 Hospital Pharmacies
- 5.1.2 Drug Stores
- 5.1.3 E-commerce
- 5.1.4 Other
- 5.2 Global Ringworm Treatment Drugs Market Size by Application
- 5.2.1 Global Ringworm Treatment Drugs Market Size Overview by Application (2021-2032)
- 5.2.2 Global Ringworm Treatment Drugs Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Ringworm Treatment Drugs Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Ringworm Treatment Drugs Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Ringworm Treatment Drugs Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Ringworm Treatment Drugs Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Ringworm Treatment Drugs Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Ringworm Treatment Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Teva Pharmaceuticals, Inc.
- 6.1.1 Teva Pharmaceuticals, Inc. Company Information
- 6.1.2 Teva Pharmaceuticals, Inc. Business Overview
- 6.1.3 Teva Pharmaceuticals, Inc. Ringworm Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Teva Pharmaceuticals, Inc. Ringworm Treatment Drugs Product Portfolio
- 6.1.5 Teva Pharmaceuticals, Inc. Recent Developments
- 6.2 Novartis AG
- 6.2.1 Novartis AG Company Information
- 6.2.2 Novartis AG Business Overview
- 6.2.3 Novartis AG Ringworm Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Novartis AG Ringworm Treatment Drugs Product Portfolio
- 6.2.5 Novartis AG Recent Developments
- 6.3 Merck & Co., In
- 6.3.1 Merck & Co., In Company Information
- 6.3.2 Merck & Co., In Business Overview
- 6.3.3 Merck & Co., In Ringworm Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Merck & Co., In Ringworm Treatment Drugs Product Portfolio
- 6.3.5 Merck & Co., In Recent Developments
- 6.4 GlaxoSmithKline Plc
- 6.4.1 GlaxoSmithKline Plc Company Information
- 6.4.2 GlaxoSmithKline Plc Business Overview
- 6.4.3 GlaxoSmithKline Plc Ringworm Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 GlaxoSmithKline Plc Ringworm Treatment Drugs Product Portfolio
- 6.4.5 GlaxoSmithKline Plc Recent Developments
- 6.5 Taro Ppharmaceutical Industries Ltd.
- 6.5.1 Taro Ppharmaceutical Industries Ltd. Company Information
- 6.5.2 Taro Ppharmaceutical Industries Ltd. Business Overview
- 6.5.3 Taro Ppharmaceutical Industries Ltd. Ringworm Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Taro Ppharmaceutical Industries Ltd. Ringworm Treatment Drugs Product Portfolio
- 6.5.5 Taro Ppharmaceutical Industries Ltd. Recent Developments
- 6.6 Perrigo Company plc
- 6.6.1 Perrigo Company plc Company Information
- 6.6.2 Perrigo Company plc Business Overview
- 6.6.3 Perrigo Company plc Ringworm Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Perrigo Company plc Ringworm Treatment Drugs Product Portfolio
- 6.6.5 Perrigo Company plc Recent Developments
- 6.7 Glenmark Pharmaceuticals Inc.
- 6.7.1 Glenmark Pharmaceuticals Inc. Company Information
- 6.7.2 Glenmark Pharmaceuticals Inc. Business Overview
- 6.7.3 Glenmark Pharmaceuticals Inc. Ringworm Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Glenmark Pharmaceuticals Inc. Ringworm Treatment Drugs Product Portfolio
- 6.7.5 Glenmark Pharmaceuticals Inc. Recent Developments
- 6.8 Chempro Group India
- 6.8.1 Chempro Group India Company Information
- 6.8.2 Chempro Group India Business Overview
- 6.8.3 Chempro Group India Ringworm Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Chempro Group India Ringworm Treatment Drugs Product Portfolio
- 6.8.5 Chempro Group India Recent Developments
- 6.9 Avik Pharma
- 6.9.1 Avik Pharma Company Information
- 6.9.2 Avik Pharma Business Overview
- 6.9.3 Avik Pharma Ringworm Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Avik Pharma Ringworm Treatment Drugs Product Portfolio
- 6.9.5 Avik Pharma Recent Developments
- 6.10 Actiza Pharmaceutical
- 6.10.1 Actiza Pharmaceutical Company Information
- 6.10.2 Actiza Pharmaceutical Business Overview
- 6.10.3 Actiza Pharmaceutical Ringworm Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Actiza Pharmaceutical Ringworm Treatment Drugs Product Portfolio
- 6.10.5 Actiza Pharmaceutical Recent Developments
7 North America by Country
- 7.1 North America Ringworm Treatment Drugs Sales by Country
- 7.1.1 North America Ringworm Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Ringworm Treatment Drugs Sales by Country (2021-2026)
- 7.1.3 North America Ringworm Treatment Drugs Sales Forecast by Country (2027-2032)
- 7.2 North America Ringworm Treatment Drugs Market Size by Country
- 7.2.1 North America Ringworm Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Ringworm Treatment Drugs Market Size by Country (2021-2026)
- 7.2.3 North America Ringworm Treatment Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Ringworm Treatment Drugs Sales by Country
- 8.1.1 Europe Ringworm Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Ringworm Treatment Drugs Sales by Country (2021-2026)
- 8.1.3 Europe Ringworm Treatment Drugs Sales Forecast by Country (2027-2032)
- 8.2 Europe Ringworm Treatment Drugs Market Size by Country
- 8.2.1 Europe Ringworm Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Ringworm Treatment Drugs Market Size by Country (2021-2026)
- 8.2.3 Europe Ringworm Treatment Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Ringworm Treatment Drugs Sales by Country
- 9.1.1 Asia-Pacific Ringworm Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Ringworm Treatment Drugs Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Ringworm Treatment Drugs Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Ringworm Treatment Drugs Market Size by Country
- 9.2.1 Asia-Pacific Ringworm Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Ringworm Treatment Drugs Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Ringworm Treatment Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Ringworm Treatment Drugs Sales by Country
- 10.1.1 South America Ringworm Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Ringworm Treatment Drugs Sales by Country (2021-2026)
- 10.1.3 South America Ringworm Treatment Drugs Sales Forecast by Country (2027-2032)
- 10.2 South America Ringworm Treatment Drugs Market Size by Country
- 10.2.1 South America Ringworm Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Ringworm Treatment Drugs Market Size by Country (2021-2026)
- 10.2.3 South America Ringworm Treatment Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Ringworm Treatment Drugs Sales by Country
- 11.1.1 Middle East and Africa Ringworm Treatment Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Ringworm Treatment Drugs Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Ringworm Treatment Drugs Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Ringworm Treatment Drugs Market Size by Country
- 11.2.1 Middle East and Africa Ringworm Treatment Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Ringworm Treatment Drugs Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Ringworm Treatment Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Ringworm Treatment Drugs Value Chain Analysis
- 12.1.1 Ringworm Treatment Drugs Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Ringworm Treatment Drugs Production Mode & Process
- 12.2 Ringworm Treatment Drugs Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Ringworm Treatment Drugs Distributors
- 12.2.3 Ringworm Treatment Drugs Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst